FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 67877-175 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA202295
Dosage form / routeTABLET · ORAL
Active ingredientsOLANZAPINE (10 mg/1)
Marketing started20120101
Package count6

External sources

Source: openFDA. Public-domain (CC0).